Imugene Limited (ASX:IMU)
Australia · Delayed Price · Currency is AUD 0.0340
-0.0020 (-5.56%)
Nov 11, 2026, 4:10 PM AEDT
Imugene Market Cap
Imugene has a market cap or net worth of 16.65 million as of November 10, 2026. It is the 40,325th most valuable company in the world and the 1,109th biggest in Australia. Its market cap has decreased by 83.75% in one year.
Market Cap
16.65M
Enterprise Value
20.32M
Revenue
2.09M
Global Rank
Country Rank
#1,109 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since September 17, 2002, Imugene's market cap has increased from 7.38M to 16.65M, an increase of 125.65%. That is a compound annual growth rate of 3.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 16.65M | -85.61% |
| Dec 31, 2025 | 115.75M | -57.94% |
| Dec 31, 2024 | 275.18M | -65.11% |
| Dec 29, 2023 | 788.60M | -15.31% |
| Dec 30, 2022 | 931.15M | -59.62% |
| Dec 31, 2021 | 2.31B | 386.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Botanix Pharmaceuticals | 24.86M |
| Miro Sciences | 17.54M |
| Radiopharm Theranostics | 17.35M |
| Algorae Pharmaceuticals | 16.22M |
| Proteomics International Laboratories | 16.04M |
| Argenica Therapeutics | 15.41M |
| ReNerve | 14.13M |
| EZZ Life Science Holdings | 14.12M |